General information
  • Disease category Nervous System diseases (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Geneva
    (BASEC)
  • Contact Pierre Nicolo pierre.nicolo@hesge.ch (BASEC)
  • Data Source(s) BASEC: Import from 16.07.2025 ICTRP: N/A
  • Last update 16.07.2025 10:00
HumRes67079 | SNCTP000006488 | BASEC2025-D0020

Advancing Upper Limb Stroke Rehab & Assistive Technology

  • Disease category Nervous System diseases (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Geneva
    (BASEC)
  • Contact Pierre Nicolo pierre.nicolo@hesge.ch (BASEC)
  • Data Source(s) BASEC: Import from 16.07.2025 ICTRP: N/A
  • Last update 16.07.2025 10:00

Summary description of the study

This clinical project aims to improve motor control of the affected arm in individuals who have suffered a stroke by combining non-invasive multifocal brain stimulation with the innovative use of a touchscreen tablet for motor learning. Currently, many post-stroke patients face difficulties with motor control, which limits their independence and quality of life. Conventional rehabilitation approaches have shown their limitations, highlighting the need for innovation. By using multifocal brain stimulation and an interactive interface via a touchscreen tablet, this project aims to optimize motor learning and enhance motor recovery in these patients. By evaluating the effectiveness of this approach, we aim to provide new perspectives for post-stroke rehabilitation and improve the quality of life for patients.

(BASEC)

Intervention under investigation

Intermittent Theta Burst Stimulation (iTBS): The Magstim®Rapid2 system (© The Magstim Company Limited, Spring Gardens, UK - Class IIa)

(BASEC)

Disease under investigation

Stroke

(BASEC)

Criteria for participation in trial
Stroke Patients 1) Age ≥ 18 years 2) First hemorrhagic or ischemic stroke ≤ 6 months 3) Unilateral hemiparesis of the upper limb with a FMA-UE score (29 ≤ Score < 58) Healthy Participants 1) Age ≥ 18 years 2) Ability to concentrate and follow the study protocol 3) Provided informed consent (BASEC)

Exclusion criteria
Stroke Patients 1) Injection of botulinum toxin in the upper limb less than 3 months before the start of the protocol 2) Patients who have experienced one or more seizures 3) Metallic object near the stimulated area Healthy Participants 1) Severe comorbidity of the non-dominant arm (traumatic, rheumatological, osteoarticular neurodegenerative diseases). 2) Inability to follow study procedures, for example due to language problems, psychological disorders, dementia, etc. of the participant 3) Current or past use of psychoactive substances, including drug use or excessive alcohol consumption (BASEC)

Trial sites

Geneva

(BASEC)

not available

Sponsor

Dr Nicolas Nicastro Médecin adjoint agrégé responsable d’unité Spéc. FMH en Neurologie Département des Neurosciences Cliniques, Service de Neurorééducation, Hôpitaux Universitaire de Genève

(BASEC)

Contact

Contact Person Switzerland

Pierre Nicolo

0792633543

pierre.nicolo@hesge.ch

Haute école de santé / University School of Health ▪ HES-SO Genève

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee Geneva

(BASEC)

Date of authorisation

16.07.2025

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Advancing stroke rehabilitation through multifocal network-based theta-burst stimulation and assistive technology: Enhancing upper limb motor learning: A single-center, randomized, sham-controlled study with parallel groups. (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available